ATE502047T1 - T-helper antigenic determinant (thd) peptide - Google Patents

T-helper antigenic determinant (thd) peptide

Info

Publication number
ATE502047T1
ATE502047T1 AT06841747T AT06841747T ATE502047T1 AT E502047 T1 ATE502047 T1 AT E502047T1 AT 06841747 T AT06841747 T AT 06841747T AT 06841747 T AT06841747 T AT 06841747T AT E502047 T1 ATE502047 T1 AT E502047T1
Authority
AT
Austria
Prior art keywords
thd
peptides
antigenic determinant
helper
helper antigenic
Prior art date
Application number
AT06841747T
Other languages
English (en)
Inventor
Cuesta Francisco Borras
Sagastibelza Juan Jose Lasarte
Egozcue Marta Ruiz
Ugarriza Pablo Sarobe
Original Assignee
Proyecto Biomedicina Cima Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proyecto Biomedicina Cima Sl filed Critical Proyecto Biomedicina Cima Sl
Application granted granted Critical
Publication of ATE502047T1 publication Critical patent/ATE502047T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
AT06841747T 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptide ATE502047T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503169A ES2310072B1 (es) 2005-12-23 2005-12-23 Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
PCT/ES2006/000695 WO2007074188A1 (es) 2005-12-23 2006-12-19 NUEVOS PEPTIDOS DETERMINANTES ANTIGENICOS T COLABORADORES (DTh)

Publications (1)

Publication Number Publication Date
ATE502047T1 true ATE502047T1 (de) 2011-04-15

Family

ID=38217710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06841747T ATE502047T1 (de) 2005-12-23 2006-12-19 T-helper antigenic determinant (thd) peptide

Country Status (12)

Country Link
US (1) US20090220533A1 (de)
EP (1) EP1978026B1 (de)
JP (1) JP2009520772A (de)
CN (1) CN101374857A (de)
AT (1) ATE502047T1 (de)
AU (1) AU2006329789A1 (de)
BR (1) BRPI0620243A2 (de)
CA (1) CA2634840A1 (de)
DE (1) DE602006020781D1 (de)
ES (1) ES2310072B1 (de)
RU (1) RU2008129731A (de)
WO (1) WO2007074188A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2756206A1 (en) 2009-03-27 2010-09-30 Academia Sinica Methods and compositions for immunization against virus
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
AU1582797A (en) 1996-01-24 1997-08-20 Epimmune, Inc. Induction of immune response against desired determinants
US6413517B1 (en) * 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
AU4224499A (en) * 1998-05-29 1999-12-13 Epimmune, Inc. Identification of broadly reactive dr restricted epitopes
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
US20040236514A1 (en) * 2001-12-13 2004-11-25 Lee Stephen C. Controlling distribution of epitopes in polypeptide sequences

Also Published As

Publication number Publication date
BRPI0620243A2 (pt) 2011-11-08
EP1978026A4 (de) 2010-03-10
JP2009520772A (ja) 2009-05-28
ES2310072A1 (es) 2008-12-16
CA2634840A1 (en) 2007-07-05
EP1978026B1 (de) 2011-03-16
CN101374857A (zh) 2009-02-25
ES2310072B1 (es) 2009-11-16
EP1978026A1 (de) 2008-10-08
DE602006020781D1 (en) 2011-04-28
AU2006329789A1 (en) 2007-07-05
RU2008129731A (ru) 2010-01-27
WO2007074188A1 (es) 2007-07-05
US20090220533A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
DE602005008996D1 (de) Radiofluorierte peptide
BRPI0506771A (pt) anticorpo, e, composição farmacêutica
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
SE0301010D0 (sv) Novel compounds
ATE491349T1 (de) Neue nutrazeutika-zusammensetzungen
MX336807B (es) Composiciones y metodos para producir una composicion.
WO2011060242A3 (en) Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
IL203943A (en) A preparation containing peptide for the prevention or treatment of allergy to house dust mites
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
TW200745003A (en) Novel compounds
ATE523514T1 (de) Tricyclische triazolische verbindungen
SMT201300093B (it) Formulazioni di vwf ricombinante liofilizzate
TW200630336A (en) Novel compounds
TW200621690A (en) Novel compounds
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
DK2018169T3 (da) Anvendelse af 4,17-beta-dihydroxyandrost-4-en-3-on til behandling af cancer
ATE411300T1 (de) Neue cysteine protease hemmers und ihre therapeutische anwendungen
SG170086A1 (en) Modified molecules which promote hematopoiesis
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
CY1114532T1 (el) (2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα
BRPI0414008B8 (pt) compostos que se ligam a um receptor de trombopoietina, composições e métodos in vitro para ativação de um receptor de trombopoietina em uma célula
NO20082989L (no) Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet
EA200600404A1 (ru) Пероральные препаративные формы кладрибина

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties